By Counterforce Health Team in Bylvay (odevixibat) —

How to Get Bylvay (odevixibat) Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Bylvay Covered by UnitedHealthcare in Pennsylvania

UnitedHealthcare requires prior authorization for Bylvay (odevixibat) in Pennsylvania, with two different policy tracks depending on your specific plan. Most plans require documented failure of at least two conventional cholestatic pruritus treatments and specialist prescribing. If denied, you have 180 days to file an internal appeal, followed by Pennsylvania's Independent External Review within 4 months of final denial. Start today by having your gastroenterologist or hepatologist check which UnitedHealthcare Bylvay policy applies to your plan via the UHC Provider Portal.

Table of Contents

Why Pennsylvania State Rules Matter for Bylvay Coverage

Pennsylvania's recent healthcare reforms create significant protections for patients seeking coverage of rare disease treatments like Bylvay. The state's Act 146 of 2022 reformed step therapy requirements, while the new Independent External Review Program launched in 2024 has overturned approximately 50% of insurance denials in its first year.

For UnitedHealthcare members in Pennsylvania, these state protections interact with national UnitedHealthcare policies in important ways:

  • Step therapy exceptions must be granted when required medications lack FDA approval for your condition
  • No forced repetition of previously failed therapies when changing plans
  • State-supervised external review provides an independent path after internal appeals
  • Expedited timelines for urgent medical situations
Note: These protections apply to fully insured commercial plans but may not cover self-funded employer plans governed by federal ERISA rules.

UnitedHealthcare's Two Bylvay Prior Authorization Policies

UnitedHealthcare uses two different national Bylvay policies depending on your specific plan design. Understanding which applies is crucial for approval success.

Medical Necessity Policy (Stricter Requirements)

For PFIC (Progressive Familial Intrahepatic Cholestasis):

  • Confirmed molecular diagnosis with genetic testing
  • Not ABCB11 variant causing complete BSEP-3 absence
  • Moderate to severe pruritus
  • Step therapy requirement: Inadequate response to at least two conventional treatments:
    • Ursodeoxycholic acid
    • Diphenhydramine
    • Cholestyramine
    • Rifampin
    • Naltrexone
    • Sertraline
  • Prescribed by gastroenterologist or hepatologist

For Alagille Syndrome:

  • Clinical diagnosis confirmed by JAG1 or NOTCH2 mutation
  • Elevated serum bile acids above normal
  • Moderate to severe pruritus
  • Failed at least two conventional treatments (same list as above)
  • Specialist prescribing required

Source: UnitedHealthcare Bylvay Medical Necessity Policy

Prior Authorization/Notification Policy (Simpler Requirements)

Some 2025 UnitedHealthcare plans use a lighter approach with no explicit step therapy:

For Both PFIC and Alagille:

  • Confirmed diagnosis
  • Pruritus associated with condition
  • No mandatory prior treatment failures
  • 12-month authorization periods

Source: UnitedHealthcare Bylvay Notification Policy

Coverage at a Glance

Requirement Medical Necessity Policy Notification Policy Where to Verify
Prior Authorization Yes Yes UHC PA Requirements
Step Therapy Required (≥2 failed treatments) Not specified Policy documents
Specialist Required Yes (GI/Hepatology) Recommended PA forms
Genetic Testing Yes (specific mutations) Not specified Clinical documentation
Authorization Period 12 months 12 months Approval letters

Turnaround Standards and Urgent Review Rights

Standard Prior Authorization Timeline

UnitedHealthcare typically processes complete Bylvay prior authorizations within 72 hours for standard requests. Electronic submissions through the UHC Provider Portal often receive faster processing.

Expedited Review Criteria

Request urgent/expedited review when delay would:

  • Seriously jeopardize life or health
  • Risk irreversible disease progression
  • Cause severe uncontrolled symptoms
  • Interfere with scheduled procedures

Expedited timeline: Decisions within 24 hours of complete submission.

Tip: Emergency department, urgent care, observation, and inpatient settings often bypass prior authorization requirements entirely.

Step Therapy Protections and Medical Exceptions

Pennsylvania's step therapy reforms provide multiple pathways to override requirements, especially valuable for rare diseases like PFIC and Alagille syndrome.

Medical Exception Criteria

Document any of the following for step therapy override:

  1. Previous failure or intolerance to required step medications
  2. Risk of serious harm from required step therapy
  3. Expected lack of effectiveness based on clinical evidence
  4. FDA indication mismatch - step drug not approved for your condition
  5. Stable control on current therapy after prior failures

Documentation Requirements

Your gastroenterologist or hepatologist should include:

  • Treatment history table with drug names, dates, doses, outcomes
  • Specific adverse events or contraindications to step therapies
  • Clinical rationale why Bylvay is medically necessary
  • Risk assessment of delaying treatment
  • Guidelines or studies supporting Bylvay use
From our advocates: We've seen step therapy overrides succeed when providers clearly document that conventional cholestatic pruritus treatments either failed to control symptoms or caused intolerable side effects like severe sedation or liver enzyme elevation. The key is specific dates and clinical outcomes, not general statements.

Continuity of Care During Plan Changes

Pennsylvania law protects patients who are stable on Bylvay when changing UnitedHealthcare plans or transitioning from other insurers.

Transition Rights

  • No forced repetition of previously completed step therapy
  • Temporary coverage during prior authorization review
  • Grace periods for ongoing specialty therapy

Required Documentation

  • Previous authorization approvals
  • Treatment response records
  • Specialist attestation of medical necessity
  • Pharmacy fill history

Pennsylvania's External Review Process

If UnitedHealthcare denies your Bylvay coverage after internal appeals, Pennsylvania's Independent External Review offers a powerful remedy.

Eligibility Requirements

  • Complete UnitedHealthcare's internal appeal process
  • Receive Final Adverse Benefit Determination letter
  • File within 4 months of final denial
  • Applies to fully insured commercial plans

Filing Process

Standard External Review:

  1. Submit request via Pennsylvania Insurance Department portal
  2. Include Final Adverse Benefit Determination letter
  3. Attach medical records and supporting evidence
  4. Decision within 45 days of complete submission

Expedited External Review:

  • For serious health threats requiring urgent treatment
  • Physician certification of medical urgency required
  • Decision within 72 hours

Success Rates

Pennsylvania's program has overturned approximately 50% of appealed denials in its first year, with particular success for medically necessary treatments initially denied by insurers.

When Counterforce Health analyzes insurance denials for rare disease treatments, we often find that external review provides the strongest pathway to coverage when internal appeals fail. The independent medical reviewers frequently recognize the limited treatment options and urgent medical needs that characterize conditions like PFIC and Alagille syndrome.

Practical Scripts for Approval

Patient Phone Script for UnitedHealthcare

"I'm calling about prior authorization for Bylvay for my [child's] PFIC/Alagille syndrome. My doctor submitted the PA request on [date]. Can you confirm which Bylvay policy applies to my plan - the Medical Necessity or Notification version? I need to know if step therapy documentation is required. My member ID is [number]."

Clinician Peer-to-Peer Request

"I'm requesting a peer-to-peer review for Bylvay prior authorization denial. This patient has confirmed [PFIC/Alagille syndrome] with genetic testing showing [specific mutation]. They've failed [specific medications] with documented [outcomes/adverse effects]. Bylvay is the only FDA-approved treatment for cholestatic pruritus in this condition. Delay risks [specific clinical consequences]."

Medical Necessity Letter Template

Include these key elements:

  • Patient identification and confirmed diagnosis with genetic testing
  • Disease severity with objective measures (bile acids, pruritus scores)
  • Prior treatment failures with specific drugs, dates, and outcomes
  • Clinical rationale for Bylvay based on FDA indication and guidelines
  • Risk of delay including potential for irreversible liver damage
  • Monitoring plan and expected outcomes

ERISA Plan Limitations

Important limitation: Pennsylvania's external review protections do not apply to self-funded employer plans governed by federal ERISA. These plans follow different appeal procedures outlined in your Summary Plan Description.

Identifying ERISA Plans

Check if your plan documents mention:

  • "Self-funded" or "self-insured"
  • ERISA appeal procedures
  • Federal court jurisdiction for disputes

ERISA Appeal Rights

  • Two levels of internal appeals
  • 180 days to file initial appeal
  • Independent review organization may be available
  • Federal court review after exhausting appeals

Quick Reference Resources

UnitedHealthcare Contacts

  • Provider Portal: uhcprovider.com
  • Member Services: Number on back of insurance card
  • Pharmacy PA: 866-889-8054 (OptumRx)

Pennsylvania Resources

Clinical Resources

  • FDA Bylvay Label: accessdata.fda.gov
  • Ipsen Medical Information: Contact manufacturer for clinical support

FAQ

How long does UnitedHealthcare prior authorization take for Bylvay in Pennsylvania? Standard requests typically take 72 hours; expedited requests are decided within 24 hours when medical urgency is documented.

What if Bylvay is non-formulary on my plan?
Non-formulary status doesn't prevent coverage - it just requires prior authorization and potentially higher copays. Focus on meeting medical necessity criteria.

Can I request expedited appeal if my initial PA is denied? Yes, if delay would seriously jeopardize health or ability to regain function. Your doctor must document the medical urgency.

Does step therapy apply if I failed treatments with a different insurer? No - Pennsylvania law prohibits forcing repetition of previously failed step therapy when documented by your provider.

What happens if Pennsylvania external review overturns the denial? UnitedHealthcare must immediately provide coverage and reimburse any out-of-pocket costs you paid during the appeal.

Are there financial assistance programs for Bylvay? Yes - Ipsen offers patient assistance programs. Contact their patient support services for eligibility information.

How do I know if my plan is subject to Pennsylvania or federal ERISA rules? Check your plan documents or contact HR. Fully insured plans through individual/small group markets typically follow Pennsylvania rules; large employer plans may be ERISA-governed.

Can a pharmacist help with prior authorization? Your specialty pharmacist can check PA status and coordinate with your doctor's office, but cannot submit the clinical documentation required for approval.

Disclaimer: This information is for educational purposes and does not constitute medical or legal advice. Insurance coverage decisions depend on your specific plan terms and clinical circumstances. Always consult with your healthcare provider and insurance plan directly for coverage determinations.

Counterforce Health specializes in turning insurance denials into successful appeals through evidence-based advocacy. Our platform analyzes denial letters, identifies the specific coverage criteria, and helps clinicians craft targeted responses that align with payer policies and clinical guidelines. By understanding both the medical necessity requirements and procedural pathways, we help patients access the treatments they need while reducing the administrative burden on healthcare providers. Visit www.counterforcehealth.org to learn how our approach can support your coverage appeals.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.